Vesicare (solifenacin) in the treatment of urinary incontinence after radical prostatectomy.

Trial Profile

Vesicare (solifenacin) in the treatment of urinary incontinence after radical prostatectomy.

Completed
Phase of Trial: Phase I

Latest Information Update: 01 Oct 2014

At a glance

  • Drugs Solifenacin (Primary)
  • Indications Urinary incontinence
  • Focus Therapeutic Use
  • Most Recent Events

    • 12 Jun 2014 Status changed from discontinued to completed to match the status with ClinicalTrials.gov record (NCT01215721).
    • 12 Jun 2014 Status changed from discontinued to completed to match the status with ClinicalTrials.gov record (NCT01215721).
    • 04 Sep 2013 The extension trial is now completed according to the ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top